Norway established in 2013 a framework for the introduction of innovations into the health care system through either a national or hospital-based health technology assessment. This framework is called the “New Method.”
In this framework, all innovations should undergo HTA before being funded. If the method concerns only one or two hospitals, the assessment shall be initiated by clinicians and ran at the hospital level. The final report is disseminated via a mini-HTA database. If the method is of national concern, it undergoes Single Technology Appraisal at national level followed by the funding decision by the group of payers (Decision Forum, Beslutningsforum).
On the 7th of May 2019, the new assessment for bone-anchored prosthesis has been initiated in a framework of New Method. The proposal for the evaluation was submitted by Oslo University Hospital in order to receive an opportunity to offer method with bone-anchored extremity prostheses, which is manufactured by a Swedish company, Integrum AB. Due to the enormous expertise in bone-anchored prostheses use, Oslo University Hospital could perform this method in order to achieve the overall money saving and medical benefits by treating patients as nowadays, only conventional prostheses are offered in, and patients are sent to Gothenburg to receive the treatment financed by the Norwegian health service.
The next steps of the assessments would be released at the web-site of the New Method.
See the full information and the proposal in Norwegian here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.